NasdaqGS:BRKRLife Sciences
How Investors Are Reacting To Bruker (BRKR) Lowered 2025 Outlook and Cost-Saving Initiatives
Bruker Corporation recently reported third-quarter 2025 earnings, showing a sequential improvement in revenue and non-GAAP earnings despite a year-over-year revenue decline and a one-time goodwill impairment charge of US$96.5 million.
Management announced progress on annual cost-saving initiatives of up to US$120 million for 2026, aiming to achieve double-digit EPS growth even as they lowered full-year 2025 guidance due to continued organic revenue headwinds.
We'll explore how Bruker's...